Effects of apolipoprotein E (apoE) isoforms, β-amyloid (Aβ) and apoE/Aβ complexes on Protein Kinase C-α (PKC-α) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts

Neurochemistry International

Volumn 38, Issue 7, 2001, Pages 615-625

  Cedazo Mínguez, Angel ^a   Wiehager, Birgitta ^a   Winblad, Bengt ^a   Hüttinger, Manfred ^b   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apolipoprotein E; APP processing; PKC translocation

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIBODY; ANTIBODY 22C11; ANTIBODY 6E10; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; FIBROBLASTS; HUMANS; ISOENZYMES; NEUROBLASTOMA; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035372336     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(00)00128-5     Document Type: Article

References (57)

1. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene
2. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease
3. Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons
4. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
5. Co-expression of β-amyloid precursor protein (β-APP) and apolipoprotein E in cell culture: Analysis of β-APP processing
6. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
7. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
8. Protein phosphorilation inhibits production of Alzheimer amyloid β/A4 peptide
9. Nicergoline stimulates protein kinase C mediated α-secretase processing of the Amyloid precursor protein in cultured human neuroblastoma SH-SY-5Ycells
10. Action of amyloid beta-protein on protein kinase C activity
11. Processing of Aβ-amyloid precursor protein and its regulation in Alzheimer Disease
12. The role of APOE polymorphisms in late-onset dementias
13. Amyloid beta protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells
14. Amyloid precursor protein secretion and beta A4 amyloid generation are not mutually exclusive
15. Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts
16. Inhibition of beta amyloid production by activation of protein kinase C
17. Apolipoprotein E and Cholesterol affect Neuronal calcium signalling: The possible relationship to β-amyloid toxicity
18. Physical interaction of apoE with amyloid precursor protein independent of the amyloid Aβ region in vitro
19. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11
20. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain
21. Conventional protein kinase (PKC)-α and novel PKC-ε, but not -δ increase the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein from cDNA transfected 3Y1 fibroblasts
22. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain)
23. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma
24. Saturation and supression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits
25. Isoform-specific binding of apolipoprotein E to beta-amyloid
26. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
29. Apolipoprotein E and the CNS response to injury
30. Beta-amyloid (1-40) increases expression of beta-amyloid precursor protein in neuronal hybrid cells
31. Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures
32. Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells
33. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
34. Differential involvement of protein kinase C isozymes in Alzheimer's disease
35. 2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease
36. Regulation of amyloid precursor protein cleavage
37. 2+-channel
38. Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4
39. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants
40. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain
41. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease
42. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
43. Increased amyloid β-peptide depositiion in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's Disease
44. Amyloid beta-protein (25-35) increases cellular APP and inhibits the secretion of APPs in human extraneuronal cells
45. Regulation of amyloid precursor protein release by protein kinase C in Swiss 3T3 fibroblasts
46. Metabolites of the β-amyloid precursor protein generated by β-secretase localize to the trans-golgi network and late endosome in 293 cells
47. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
48. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer's disease brain are related to apolipoprotein E genotype
49. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease
50. Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity
51. Atypical low density lipoprotein binding site that may mediate lipoprotein-induced signal transduction
52. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain
53. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
54. Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
55. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
56. Apolipoprotein E: A patohological chaperone protein with cerebral and systemic amyloid
57. Differential regulation of APP secretion by apolipoprotein E3 and E4